On the 10th, NeoPharm's medical skincare brand, ZEROID, announced that the criteria for selecting products in the dermatological cosmetics market are shifting towards research-based efficacy validation.

This transition reflects a broader market trend emphasizing the importance of substantiated performance in skincare formulations, which is increasingly influencing consumer choices.As functional cosmetic products centered on skin barrier enhancement, calming effects, and specific ingredients like PDRN gain traction, brands that traditionally relied on clinical environments are expanding into mass distribution channels, such as Olive Young.

This transition not only reflects a diversification of options available to consumers but also signifies an evolution in dermatological products transitioning into popular skincare regimens, thereby broadening the customer base.With the rise of functional ingredients throughout the industry, the lines between dermatological and standard cosmetics are becoming blurred.

Consequently, evaluation criteria are gravitating towards the verification of effectiveness, creating a competitive landscape that prioritizes research over superficial claims.In this environment, ZEROID is leveraging its strengths in skin barrier technology and extensive clinical data accumulation to enhance product efficacy.

The brand's innovative approach utilizes its proprietary technology, MLE®, which mimics natural skin environments, and includes defensamide to protect against external irritants, thus focusing not merely on hydration or calming but improving compromised skin health.ZEROID's research is further supported by collaborations with dermatologists, yielding evidence that its 'ZEROID Intensive Rich Cream' significantly alleviates symptoms of dry, itchy skin compared to groups using only steroid-based treatments.

This study has been validated through publication in the internationally recognized 'Dermatology and Therapy' journal, indicating that ZEROID’s product efficacy is not just theoretically sound, but clinically validated.